- In a new study, researchers says low-dose aspirin could lower risk of type 2 diabetes in people over 65.
- Earlier studies have indicated that regular use of low-dose aspirin can cause bleeding.
- Doctors not involved with study say that although the new study makes good points, there are too many factors to say regular aspirin use is safe.
A new analysis out this week states that the use of low-dose aspirin could potentially lower the risk of type 2 diabetes in people over 65.
The report will be presented in early October at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany.
The authors did a follow-up study of the ASPREE trial – a double-blind, placebo-controlled trial of aspirin, the principal results of which were published in the New England Journal of Medicine in 2018.
This original study stated that aspirin conferred a 38% increased risk of major hemorrhage in older adults without any reduction in incidence of cardiovascular disease.
In the new study, researchers, led by Sophia Zoungas, a professor in the school of public health and preventive medicine at the Monash University in Melbourne, Australia, said in a statement that the researchers’ work shows that using a low dose (100 mg daily) of aspirin daily among adults 65 and older is associated with a 15% lower risk of developing type 2 diabetes.
The team said the results show anti-inflammatory agents such as aspirin warrant further study in the prevention of diabetes.
The authors said the effect of aspirin on incident type 2 diabetes among older adults remains uncertain.
This study investigated the randomized treatment effect of low-dose aspirin on incident diabetes and fasting plasma glucose (FPG) levels among older adults.
The latest study looked at community-dwelling people 65 or over who…
Read the full article here